Therapy preferences in melanoma treatment--willingness to pay and preference of quality versus length of life of patients, physicians and healthy controls.
about
Access to new cancer medicines in Australia: dispelling the myths and informing a public debate.Volume matters in the systemic treatment of metastatic pancreatic cancer: a population-based study in the NetherlandsPerceptions of Oncologists, Healthcare Policy Makers, Patients and the General Population on the Value of Pharmaceutical Treatments in Oncology.Patient and oncologist preferences for attributes of treatments in advanced melanoma: a discrete choice experiment.Willingness to pay for a cure of low-risk melanoma patients in Germany.
P2860
Therapy preferences in melanoma treatment--willingness to pay and preference of quality versus length of life of patients, physicians and healthy controls.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Therapy preferences in melanom ...... ysicians and healthy controls.
@ast
Therapy preferences in melanom ...... ysicians and healthy controls.
@en
Therapy preferences in melanom ...... ysicians and healthy controls.
@nl
type
label
Therapy preferences in melanom ...... ysicians and healthy controls.
@ast
Therapy preferences in melanom ...... ysicians and healthy controls.
@en
Therapy preferences in melanom ...... ysicians and healthy controls.
@nl
prefLabel
Therapy preferences in melanom ...... ysicians and healthy controls.
@ast
Therapy preferences in melanom ...... ysicians and healthy controls.
@en
Therapy preferences in melanom ...... ysicians and healthy controls.
@nl
P2860
P1433
P1476
Therapy preferences in melanom ...... ysicians and healthy controls.
@en
P2093
Lucie Heinzerling
Ramona Krammer
P2860
P304
P356
10.1371/JOURNAL.PONE.0111237
P407
P577
2014-11-04T00:00:00Z